FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 53 filers reported holding FATE THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $111,000 | -55.2% | 34,107 | -37.5% | 0.04% | -45.0% |
| Q1 2017 | $248,000 | +588.9% | 54,598 | +160.9% | 0.08% | +1042.9% |
| Q2 2016 | $36,000 | -67.3% | 20,925 | -35.6% | 0.01% | -41.7% |
| Q4 2015 | $110,000 | -83.0% | 32,495 | -73.2% | 0.01% | -80.6% |
| Q3 2015 | $646,000 | +22.1% | 121,151 | +48.1% | 0.06% | +19.2% |
| Q2 2015 | $529,000 | – | 81,797 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 716,392 | $11,126,000 | 12.18% |
| Polaris Venture Management Co. V, L.L.C. | 1,139,783 | $17,701,000 | 10.06% |
| Grosvenor Holdings, L.L.C. | 2,285,714 | $35,497,000 | 6.41% |
| Redmile Group, LLC | 11,216,809 | $174,197,000 | 5.83% |
| Casdin Capital, LLC | 2,550,000 | $39,601,500,000 | 4.10% |
| DAFNA Capital Management LLC | 470,000 | $7,299,000 | 2.74% |
| Ghost Tree Capital, LLC | 350,000 | $5,436,000 | 1.38% |
| Artal Group S.A. | 2,000,000 | $31,060,000 | 1.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,952,897 | $30,328,000 | 1.24% |
| Copernicus Capital Management, LLC | 75,000 | $1,165,000 | 1.08% |